Armen Yuri Gasparyan investigador
Gasparyan, Armen Yuri
VIAF ID: 311812266 (Personal)
Permalink: http://viaf.org/viaf/311812266
Preferred Forms
- 100 0 _ ‡a Armen Yuri Gasparyan ‡c investigador
-
- 100 1 _ ‡a Gasparyan, Armen Yuri
-
- 100 1 _ ‡a Gasparyan, Armen Yuri
4xx's: Alternate Name Forms (8)
Works
Title | Sources |
---|---|
Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research. | |
Aspirin and clopidogrel resistance: methodological challenges and opportunities. | |
Behçet's Disease: an Insight from a Cardiologist's Point of View. | |
Behçet's Disease as a Model of Venous Thrombosis. | |
Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates | |
Cardiac complications in rheumatoid arthritis in the absence of occlusive coronary pathology | |
Cardiovascular risk and inflammation: pathophysiological mechanisms, drug design, and targets | |
Celebrating the Latest Release of the Journal Impact Factors: Thinking Globally, Acting Locally | |
Choosing the target journal: do authors need a comprehensive approach? | |
Colchicine as an anti-inflammatory and cardioprotective agent. | |
Combined Rewarding Mechanisms Can be Implemented to Incentivize the Best Reviewers | |
Comprehensive Approach to Open Access Publishing: Platforms and Tools | |
Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors. | |
eComment: treatment of pulmonary artery aneurysm in Behcet's disease - few things can make big differences | |
Editing, Publishing and Aggregating Video Articles: Do We Need a Scholarly Approach? | |
Editorial: Switching to biological agents in autoimmune and autoinflammatory disorders: current targets and therapy | |
Educating science editors: is there a comprehensive strategy? | |
EMBRACING SOCIAL MEDIA FOR GENERATING AND TESTING HYPOTHESES | |
Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation. | |
The first Russian seminar on science communication. | |
Further expanding possibilities of successful stem cell transplantation in coronary artery disease/an alternative approach of stem cell delivery to myocardium: combined usage of antegrade coronary arterial infusion and retrograde venous obstruction | |
Highly cited papers in Takayasu arteritis on Web of Science and Scopus: cross-sectional analysis | |
How to Act When Research Misconduct Is Not Detected by Software but Revealed by the Author of the Plagiarized Article | |
Information and misinformation on COVID-19 | |
The Journal Impact Factor: Moving Toward an Alternative and Combined Scientometric Approach. | |
Mean platelet volume: a link between thrombosis and inflammation? | |
Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-α therapy | |
Moving towards online rheumatology education in the era of COVID-19 | |
Myocardial ischemia in Wegener's granulomatosis: coronary atherosclerosis versus vasculitis. | |
Open access: changing global science publishing. | |
Peer review in scholarly biomedical journals: a few things that make a big difference | |
Plagiarism in the Context of Education and Evolving Detection Strategies | |
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. | |
The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases | |
Platelets in rheumatoid arthritis: exploring the anti-inflammatory and antithrombotic potential of TNF inhibitors. | |
Predatory Publishing Is a Threat to Non-Mainstream Science | |
The Pressure to Publish More and the Scope of Predatory Publishing Activities | |
Promoting transparent and accurate reporting of research studies in rheumatology: endorsement of reporting guidelines in rheumatology journals | |
The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases | |
Reflecting on the achievements and looking to the future of an established rheumatology journal. | |
Researcher and Author Impact Metrics: Variety, Value, and Context. | |
Researcher and Author Profiles: Opportunities, Advantages, and Limitations. | |
Researchers and editors at the heart of science communication | |
Rewarding peer reviewers: maintaining the integrity of science communication | |
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications | |
Scholarly publishing and journal targeting in the time of the Coronavirus Disease 2019 (COVID-19) pandemic: a cross-sectional survey of rheumatologists and other specialists | |
Scientific author names: errors, corrections, and identity profiles | |
Scientific Hypotheses: Writing, Promoting, and Predicting Implications | |
Selecting your editorial board: maintaining standards | |
Self-correction in biomedical publications and the scientific impact | |
Specialist Bibliographic Databases. | |
Statement on Publication Ethics for Editors and Publishers | |
Statistical data presentation: a primer for rheumatology researchers | |
Systematic and open identification of researchers and authors: focus on open researcher and contributor ID | |
Thoughts on impact factors and editing of medical journals | |
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad | |
An ultrastructural analysis of platelets, erythrocytes, white blood cells, and fibrin network in systemic lupus erythematosus. | |
Updated Editorial Guidance for Quality and Reliability of Research Output | |
Upgrading instructions for authors of scholarly journals | |
The urge to publish more and its consequences | |
The use of carotid artery ultrasonography in different clinical conditions | |
Vasculitis, left bundle branch block, and Raynaud's phenomenon as a manifestation of familial Mediterranean fever / Giuseppe Cocco. The emering issue of cardiovascular involvement in familial Mediterranean fever |